Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.24 - $0.52 $3.49 Million - $7.55 Million
14,526,721 Added 155.56%
23,864,868 $8.11 Million
Q4 2022

Feb 10, 2023

BUY
$0.22 - $1.04 $6,897 - $32,606
31,352 Added 0.34%
9,338,147 $2.43 Million
Q3 2022

Nov 14, 2022

BUY
$0.25 - $2.4 $11,116 - $106,720
44,467 Added 0.48%
9,306,795 $8.17 Million
Q2 2022

Aug 12, 2022

BUY
$1.22 - $3.05 $4.57 Million - $11.4 Million
3,743,995 Added 67.85%
9,262,328 $11.7 Million
Q1 2022

May 13, 2022

BUY
$2.64 - $4.67 $5.88 Million - $10.4 Million
2,226,502 Added 67.64%
5,518,333 $16.9 Million
Q4 2021

Feb 14, 2022

BUY
$4.4 - $8.8 $1.19 Million - $2.38 Million
270,341 Added 8.95%
3,291,831 $14.7 Million
Q3 2021

Nov 12, 2021

BUY
$7.44 - $13.99 $22.5 Million - $42.3 Million
3,021,490 New
3,021,490 $22.9 Million

Others Institutions Holding SMFR

About Sema4 Holdings Corp.


  • Ticker SMFR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 380,641,984
  • Market Cap $129M
  • Description
  • Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...
More about SMFR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.